Sukhatme Mayukh
Sukhatme Mayukh, PRES, CIO, reported a transaction classified as exercise at Roivant Sciences Ltd. involving 136942.000000 shares for an estimated $0.00. Reported holdings after the transaction were 13559537.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 19, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ROIV price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001140361-26-033637 Common Shares
- Transaction date
- Aug 18, 2026 Filed Aug 19, 2026, 01:00 AM · 1d delay
- Shares
- 136,942 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 13,559,537 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President & CIO
- F1
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.34, inclusive. The reporting person undertakes to provi…
- F2
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.85, inclusive. The reporting person undertakes to provi…
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $37.10, inclusive. The reporting person undertakes to provi…
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.30, inclusive. The reporting person undertakes to provi…
- F5
Award of stock options to purchase Common Shares that is fully vested.
0 other transactions
0 recent txs